Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ken Frazier
Pharma
Merck CEO Robert Davis receives 9% pay hike to $20.3M
Merck CEO Robert Davis has cracked the $20 million mark in annual pay. Davis, 57, received a 9% bump in pay in 2023 to $20.3 million.
Kevin Dunleavy
Apr 12, 2024 10:27am
Merck CEO Davis touts potential of CV drug candidates
Oct 27, 2022 12:02pm
Merck, during a transition year, doled out nearly $30M to CEOs
Apr 5, 2022 11:58am
Merck's chief patient officer is retiring in May
Mar 2, 2022 3:24pm
